Acquisition boosts Symyx Research Services in Life Sciences and expands offering into Biologic Formulations

21-Aug-2008 - USA

Symyx Technologies, Inc. has announced the acquisition of Integrity Biosolution, LLC in an all-cash transaction. IntegrityBio offers contract formulation research and analytical services, providing formulation and stability solutions for large molecule biopharmaceuticals along with Good Manufacturing Practices (GMP) fill/finish services for Phase I and II clinical trial volumes. Specific terms of the acquisition were not disclosed.

The acquisition expands Symyx's Research Service offerings in life sciences into biologic formulations, complementing its existing chemical formulations services. According to the company, the combination of Symyx and IntegrityBio creates a differentiated set of large molecule formulation services to customers in the pharmaceutical and biotechnology industries by combining IntegrityBio's formulation expertise with Symyx's advanced high-throughput research and informatics capabilities.

Other news from the department business & finance

These products might interest you

Genomics & Analytical Services

Genomics & Analytical Services by Azenta

Integrated Genomics & Analytical Services from Azenta Life Sciences

Discovery can be challenging work. Until you find the right genomics partner.

analytical services
Pharmaceutical Development Services

Pharmaceutical Development Services by AR2i

Take Advantage of AR2i's Analytical Knowledge and Unique Expertise

Our Pharmaceutical Laboratory Services According to the European Pharmacopoeia or Client Needs

Loading...

More news from our other portals

All FT-IR spectrometer manufacturers at a glance